BB BIOTECH AG 13D and 13G filings for Wave Life Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 10:13 am Unchanged |
2023-12-31 | 13G | Wave Life Sciences Ltd. WVE |
BB BIOTECH AG | 4,494,458 3.700% |
0 (Unchanged) |
Filing |
| 2023-02-14 4:08 pm Sale |
2022-12-31 | 13G | Wave Life Sciences Ltd. WVE |
BB BIOTECH AG | 4,494,458 5.200% |
-108,400 (-2.36%) |
Filing |
| 2022-02-11 4:42 pm Purchase |
2021-12-31 | 13G | Wave Life Sciences Ltd. WVE |
BB BIOTECH AG | 4,602,858 7.800% |
2,000,000 (+76.84%) |
Filing |
| 2021-02-12 4:48 pm Purchase |
2020-12-31 | 13G | Wave Life Sciences Ltd. WVE |
BB BIOTECH AG | 2,602,858 5.300% |
200,000 (+8.32%) |
Filing |